Biocides Market Expected to Reach USD 10,745.7 Million by 2020

The global market for biocides is expected to reach USD 10,745.7 million by 2020, according to a new study by Grand View Research, Inc. Growing population coupled with growing concerns for industrial waste water treatment is expected to drive biocide demand over the next six years. In addition, positive outlook on key application markets such as textiles, paints and coatings, primarily in Asia Pacific, Latin America and Eastern Europe, is also expected to boost the demand for biocides over the forecast period. 

Halogen compounds dominated the biocide product space, accounting for over 27% of global market revenue in 2013. However, environmental concerns, regarding the disposal and impact of halogen-based compounds are expected to reduce market penetration for these products by 2020. Phenolic biocides are expected to be the fastest growing product segment, at an estimated CAGR of 6.9% from 2014 to 2020.   

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/biocides-industry

Further Key findings from the study suggest:

• The global market for biocides was estimated to be USD 7,308.0 million in 2012, and is expected to grow at a CAGR of 5% from 2014 to 2020.
• North America is expected to continue its dominance in the global market and is expected to account for over 40% of the total market by the end of 2020. Asia Pacific is expected to be the fastest growing regional market, with market revenue expected to reach USD 3,454.7 million by 2020, at a CAGR of 6.2% from 2014 to 2020.
• Water treatment applications are expected to continue to dominate biocide demand, and are estimated to account for over 24% of global revenue by 2020. Regulatory framework for enforcing industrial water treatment standards is expected to have a positive impact on the market. Water treatment is also expected to be the fastest growing application market for biocides at an estimated CAGR of 6.2% from 2014 to 2020.
• The global market for biocides is moderately concentrated with top four participants, including Arch Chemical, ISP, Dow Microbial Control and Troy Corporation, accounting for over 55% of the total demand in 2013. Some of the other significant market participants for biocides include Thor Specialties, DuPont, Lanxess, Akzo Nobel and BASF.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biocides-market

Profitable Advantages of Investment in Smart Polymers Market

The global smart polymers market is expected to reach USD 20.02 billion by 2025, according to a new report by Grand View Research, Inc. Biomedical & biotechnology was the prominent segment and accounted for approximately 45.5% of the overall revenue in 2015. Smart polymers are used widely in the biomedical & biotechnology sector for drug delivery systems, tissue engineering, bioseparation, and biocatalyst.

Stimuli-responsive materials undergo various physicochemical changes when they respond to external stimuli such as temperature, pH, chemical ions, enzymes, sound, light, and other factors. Furthermore, these products are not only adaptive to the changes in surroundings but are also capable of regaining their original properties. The attributes mentioned above make smart polymers favorable for use in producing self-regulated drug delivery systems, tissue engineering systems, bioseparation devices, and reversible biocatalysts.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/smart-polymers-market

Further key findings from the report suggest:

• The North America smart polymers industry was valued at USD 1.16 billion in 2015 and is expected to show high gains on account of technological advancement in the major end-use industries such as biotechnology, biomedical engineering, and medical & healthcare. This scenario is likely to be reflected in the U.S., which constituted 88.9% revenue in the North America region.
• Europe held the second-largest share of the total market in 2015 accounting for 34.8% of the volume share. Healthcare & medical services, research & development in nanomedicine, and use of effective diagnostic devices are some of the key growth contributing trends in Europe region.
• Strict environmental regulations governing the use of conventional polymers coupled with rising health awareness among consumers are a few of the socio-economic factors that are considered to impact the Europe healthcare and biomedical industry positively.
• The industry is dominated by major participants including Advanced Polymer Materials Inc., BASF SE, Nippon Shokubai, Advanced Biopolymers AS, FMC Corporation, Autonomic Materials, Nexgenia Corporation, Covestro AG, Lubrizol Corporation, Sigma-Aldrich Corporation, and Acros Organics.
• Prominent market participants such as Autonomic Materials, Inc. is engaged in manufacturing of smart polymeric materials that are capable of adapting and repairing themselves post any damage imposed by the external environment.

Access press release of this research report by Grand View Research:http://www.grandviewresearch.com/press-release/global-smart-polymers-market

Rapid Increase in Cancer Diagnostics Market - Key Factors, Market Segments Regions and Industry Forecasts Analysis to 2025

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth.

In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina,Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further Key Findings from the Study Suggest:

• Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space.
• The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.
• In 2015, North America dominated the global space with the largest revenue share of more than 40%.
• Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period.
• The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.
• Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH.
• Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic,Inc.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market

HIV-1 Therapeutics Market is Growing At a Rapid Pace - Market Analysis and Forecast to 2025

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one of the most challenging public health issues worldwide.

The key factors responsible for driving the market growth include the increasing incidence of HIV infections especially amongst the youth due to unprotected sexual practices, exposure to needles or syringes contaminated with infected body fluids or tissues, lack of awareness regarding transmission risk factors, etc.The estimated number of people suffering from HIV in 2015 was recorded to be more than 35 million according to AVERT, a UK-based HIV and AIDS charity.

HIV has vastly affected people from developing and under developed countries, mainly the Asian and African regions. As this infection is not curable at present, the primary aim of antiretroviral therapy is to suppress viral replication in patients usinganti-retroviral agents that are grouped into six different drug classes based on their mechanism of action.

The combination therapy entails medicines from at least two to three drug classes as each class targets different steps in the HIV lifecycle. The combination of drugs is chosen based on patients’ medical history, predisposition to adverse effects of antiretroviral drugs, co-infections with other diseases, and others.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/human-immunodeficiency-virus-hiv-1-therapeutics-market

Further Key Findings from the Study Suggest:

• NRTIs were the largest class of drugs available in the market in 2015 accounting for over 40% of total drugs available in this vertical
• Integrase inhibitors segment is expected to be the fastest growing class of antiretroviral drugs owing to the expected launch of additional integrase inhibitors by major players such as Gilead Sciences, In. and Merck & Co., Inc.
• In 2015, North America held the largest market share in 2015 with a share of over 35%. Easier access to diagnostic facilities is one of the key factors supporting sector expansion in this region.
• Asia Pacific is projected to be the fastest growing regional segment and will retain its position over the forecast period owing to the enhancing healthcare infrastructure and presence of suitable government initiatives favoring growth
• Gilead Sciences, Inc. was the leader in HIV-1 therapeutics sector with respect to market share and drug portfolio, followed byViiV Healthcare in 2015. In addition, in the coming years other small players are expected to enter this sector with their pipeline drugs.
• Other important players in this industry include AbbVie, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-human-immunodeficiency-virus-hiv-1-therapeutics-market

Future Business Opportunities in Coagulation Analyzers & Reagents Market

The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

• Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
• Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
• Automatic reflex testing, repeat testing, and redilution.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market

Further key findings from the study suggest:

• Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
• Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
• Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
• Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
• The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
• Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
• For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-coagulation-analyzers-market